Investor Relations | Corporate Information

October 31, 2025	Summary of Consolidated Financial Results for the Second Quarter of FY2025. (pdf, 187KB)
October 31, 2025	Second quarter business summary FY2025. (pdf, 664KB)
August 29, 2025	Corporate Report 2025 (Annual Report FY2024) (pdf, 1.2MB)
July 31, 2025	Summary of Consolidated Financial Results for the First Quarter of FY2025. (pdf, 175KB)
July 31, 2025	First quarter business summary FY2025. (pdf, 549KB)
June 5, 2025	Notice Concerning Recording of Gain on Sales of Investment Securities (Extraordinary Income) (pdf, 149KB)
May 27, 2025	Notice of the 93rd Ordinary General Meeting of Shareholders. (pdf, 708KB)
May 14, 2025	Summary of Consolidated Financial Results for the Fiscal Year 2024. (pdf, 257KB)
May 14, 2025	Business summary FY2024. (pdf, 1,200KB)
April 21, 2025	Discovery that citrate, which keeps the body's internal environment weakly alkaline, is effective in preventing or treating peripheral neuropathy induced by anticancer drugs. (pdf, 445KB)
January 31, 2025	Summary of Consolidated Financial Results for the Third Quarter of FY2024. (pdf, 209KB)
January 31, 2025	Third quarter business summary FY2024. (pdf, 423KB)
October 31, 2024	Summary of Consolidated Financial Results for the Second Quarter of FY2024. (pdf, 186KB)
October 31, 2024	Second quarter business summary FY2024. (pdf, 674KB)
August 30, 2024	Corporate Report 2024 (Annual Report FY2023) (pdf, 2.2MB)

IR Calendar